Cargando…
ADAM12-L is a direct target of the miR-29 and miR-200 families in breast cancer
BACKGROUND: ADAM12-L and ADAM12-S represent two major splice variants of human metalloproteinase-disintegrin 12 mRNA, which differ in their 3′-untranslated regions (3′UTRs). ADAM12-L, but not ADAM12-S, has prognostic and chemopredictive values in breast cancer. Expression levels of the two ADAM12 sp...
Autores principales: | Duhachek-Muggy, Sara, Zolkiewska, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352249/ https://www.ncbi.nlm.nih.gov/pubmed/25886595 http://dx.doi.org/10.1186/s12885-015-1108-1 |
Ejemplares similares
-
Phenotypic Diversity of Breast Cancer-Related Mutations in Metalloproteinase-Disintegrin ADAM12
por: Qi, Yue, et al.
Publicado: (2014) -
Alternative mRNA Splicing Generates Two Distinct ADAM12 Prodomain Variants
por: Duhachek-Muggy, Sara, et al.
Publicado: (2013) -
Metalloprotease-disintegrin ADAM12 actively promotes the stem cell-like phenotype in claudin-low breast cancer
por: Duhachek-Muggy, Sara, et al.
Publicado: (2017) -
Plasma levels of miR‐29b and miR‐200b in type 2 diabetic retinopathy
por: Dantas da Costa e Silva, Maria Enoia, et al.
Publicado: (2018) -
MiR200 and miR302: Two Big Families Influencing Stem Cell Behavior †
por: Balzano, Francesca, et al.
Publicado: (2018)